Figure 4: Immunohistochemical results. (a) Tumor cells showing diffuse vimentin positivity, Diaminobenzidine ×200; (b) Focal CD10 positivity within tumor cells, DAB ×100; (c) Stromal component displaying cytoplasmic MIC2 positivity, DAB ×200; (d) Progesterone receptor positivity within stromal cells, especially those with decidual morphology, DAB ×400; (e) Focal calretinin positivity within stromal cells, DAB ×400 and (f) MIB1 highlighting 8-10% tumor cell nuclei, DAB ×200